Dr Yi Lin is a consultant and associate professor in the Division of Hematology and Experimental Pathology at Mayo Clinic, Rochester, Minnesota, USA. Her practice is in lymphoma and multiple myeloma. She has an NIH-funded laboratory and clinical research program in tumor immunology, immunotherapy, and biomarkers development, with a cell therapy focus. Her laboratory program focuses on myeloid cells as immunotherapy targets; novel cell-based immunotherapy development; and predictive biomarkers in immunotherapy. She is the Principal Investigator (PI) and co-PI of multiple clinical trials testing novel dendritic cell vaccine combination immunotherapy and CAR-T therapy. She is the medical director for the Immune Effector Cell Program at Mayo Clinic, Rochester. As the chair of the Cell Therapy Cross-Disciplinary Group at Mayo Clinic Cancer Center, she also oversees the cancer cell therapy clinical research portfolio and the clinical practice for CAR-T therapy across all three Mayo sites in Minnesota, Arizona, and Florida.
EM-81044 - Date of preparation: November 2021